GW Pharmaceuticals CEO: Curbing Canada’s Hashish Dark Market | Infected Money | CNBC
GW Pharmaceuticals CEO Justin Gover tells Jim Cramer why it’s vital to unfold awareness of the well being advantages of medication derived from cannabis and FDA approval of its cannabis-primarily…
Read more »